Fresh analysis indicates that individuals who discontinue popular slimming jabs like Mounjaro or Wegovy may regain shed pounds much more quickly than those who halt conventional lifestyle programs.
Findings released in a leading health publication demonstrates that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month upon discontinuation.
"People buying such medications need to be cognizant of the risk of rapid weight regain when the treatment concludes," warns expert Dr. Susan Jebb.
That rate of regain implies a return to starting weight within about one and a half years.
Analyzing Approaches
The research, which examined 37 of studies involving over 9,000 of participants, contrasted the results of GLP-1 agonists with older methods.
Researchers point out that individuals who lose weight through lifestyle changes alone typically experience a less rapid weight regain—perhaps 100 grams monthly—once they finish.
Explaining the Quick Regain
Nutrition scientists suggest the mode of action of the jabs is key to understanding the heightened weight return.
The injections copy a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing the hormone levels far above than normal may cause the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' leads to appetite is no longer kept in check, making overeating a significant risk."
A Chronic Condition?
The NHS suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals argue that, given the likelihood of relapse, the treatment is often ongoing.
This perspective is supported by pharmaceutical companies, who note that the findings "highlight the long-term nature of excess weight," akin to managing conditions like hypertension.
Patient Accounts
People who have stopped the jabs explain a intense return of appetite.
"It felt as if a trigger activating and you're instantly extremely hungry," described a patient.
This difficulty is worsened if patients have not adopted lasting lifestyle or habit modifications during therapy.
Widespread Interest
Recent estimates show that a significant number of people in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Adoption is greater among females than males.
- The middle-aged demographic shows the highest level of interest.
- Many access the medications through private healthcare rather than public health services.
Ultimately, experts emphasize that while the jabs are potent tools for shedding pounds, they are not a standalone solution and lasting health benefits likely depends on integrated behavioural management.
